{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:23:16Z","timestamp":1773937396678,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s12012-014-9298-3","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T15:06:33Z","timestamp":1417446393000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Total Flavones of Choerospondias axillaris Attenuate Cardiac Dysfunction and Myocardial Interstitial Fibrosis by Modulating NF-\u03baB Signaling Pathway"],"prefix":"10.1007","volume":"15","author":[{"given":"Bei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiumei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"9298_CR1","doi-asserted-by":"crossref","first-page":"H543","DOI":"10.1152\/ajpheart.1999.276.2.H543","volume":"276","author":"C Li","year":"1999","unstructured":"Li, C., Browder, W., & Kao, R. L. (1999). Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. American Journal of Physiology-Heart and Circulatory Physiology, 276, H543\u2013H552.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"9298_CR2","doi-asserted-by":"crossref","first-page":"H530","DOI":"10.1152\/ajpheart.00549.2006","volume":"292","author":"Y Onai","year":"2007","unstructured":"Onai, Y., Suzuki, J., Maejima, Y., Haraguchi, G., Muto, S., Itai, A., & Isobe, M. (2007). Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology, 292, H530\u2013H538.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"9298_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCRESAHA.108.189746","volume":"104","author":"L Timmers","year":"2009","unstructured":"Timmers, L., van Keulen, J. K., Hoefer, I. E., Meijs, M. F., van Middelaar, B., den Ouden, K., et al. (2009). Targeted deletion of nuclear factor kappa B p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circulation Research, 104, 699\u2013706.","journal-title":"Circulation Research"},{"key":"9298_CR4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ejcts.2004.07.043","volume":"26","author":"K Trescher","year":"2004","unstructured":"Trescher, K., Bernecker, O., Fellner, B., Gy\u00f6ngy\u00f6si, M., Krieger, S., Demartin, R., et al. (2004). Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart. European Journal of Cardio-thoracic Surgery, 26, 960\u2013967.","journal-title":"European Journal of Cardio-thoracic Surgery"},{"key":"9298_CR5","first-page":"12","volume":"16","author":"T Jin","year":"2011","unstructured":"Jin, T. (2011). The clinical research of Guangzao fufang capsule on coronary disease. Chinese Journal of Ethnomedicine and Ethnopharmacy, 16, 12\u201314.","journal-title":"Chinese Journal of Ethnomedicine and Ethnopharmacy"},{"key":"9298_CR6","unstructured":"Li, D. L. (2009). The protecting effects and mechanisms of TFC on the myocardium during the acute myocardial infarction. Jilin, China: Jilin University Press."},{"key":"9298_CR7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.foodchem.2007.05.068","volume":"106","author":"H Wang","year":"2008","unstructured":"Wang, H., Gao, X. D., Zhou, G. C., Cai, L., & Yao, W. B. (2008). In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit. Food Chemistry, 106, 888\u2013895.","journal-title":"Food Chemistry"},{"key":"9298_CR8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1360\/csb2004-49-8-784","volume":"20","author":"YM Yang","year":"2004","unstructured":"Yang, Y. M., Qin, J. M., Xu, J. H., Zhou, E. F., Feng, G. Q., & Bai, Y. F. (2004). Effect of total flavones of choerospondias axillaries fructus on L-type Ca2+ current, transient outward K+ and intracellular free Ca2+ of ventricular myocytes in rats. Chinese Pharmacology Bulletin, 20, 784\u2013788.","journal-title":"Chinese Pharmacology Bulletin"},{"key":"9298_CR9","first-page":"185","volume":"24","author":"X Zhang","year":"2001","unstructured":"Zhang, X., Bao, B., Wang, Z., Na, R., Sun, F., & Li, B. (2001). Protective effect of total flavonoids of fructus choerospondiatis on adriamycin-induced rat cardiac peroxidation. Zhong Yao Cai, 24, 185\u2013187.","journal-title":"Zhong Yao Cai"},{"key":"9298_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12012-013-9238-7","volume":"14","author":"C Li","year":"2014","unstructured":"Li, C., He, J., Gao, Y., Xing, Y., Hou, J., & Tian, J. (2014). Preventive effect of total flavones of Choerospondias axillaries on ischemia\/reperfusion-induced myocardial infarction-related MAPK signaling pathway. Cardiovascular Toxicology, 14, 145\u2013152.","journal-title":"Cardiovascular Toxicology"},{"key":"9298_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10557-007-6042-2","volume":"21","author":"J Ao","year":"2007","unstructured":"Ao, J., Feng, H., & Xia, F. (2007). Transforming growth factor and nuclear factor Kappa B mediated prophylactic cardioprotection by total flavonoids of fructus chorspondiatis in myocardial ischemia. Cardiovascular Drugs and Therapy, 21, 235\u2013241.","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"9298_CR12","first-page":"81","volume":"36","author":"HY Fan","year":"2005","unstructured":"Fan, H. Y., Sai, Y., Aodeng, G., & Song, T. (2005). Research on extracting process of flavonoids from Choerospondias axillaxi. Acta Scientiarum Naturalium Universitatis NeiMongol, 36, 81\u201383.","journal-title":"Acta Scientiarum Naturalium Universitatis NeiMongol"},{"key":"9298_CR13","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fct.2012.01.024","volume":"50","author":"C Li","year":"2012","unstructured":"Li, C., Gao, Y., Tian, J., Xing, Y., Zhu, H., & Shen, J. (2012). Long-term oral Asperosaponin VI attenuates cardiac dysfunction, myocardial fibrosis in a rat model of chronic myocardial infarction. Food and Chemical Toxicology, 50, 1432\u20131438.","journal-title":"Food and Chemical Toxicology"},{"key":"9298_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejphar.2007.02.052","volume":"564","author":"MG Agelaki","year":"2007","unstructured":"Agelaki, M. G., Pantos, C., Korantzopoulos, P., Tsalikakis, D. G., Baltogiannis, G. G., Fotopoulos, A., & Kolettis, T. M. (2007). Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. European Journal of Pharmacology, 564, 150\u2013157.","journal-title":"European Journal of Pharmacology"},{"key":"9298_CR15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.yjmcc.2007.03.808","volume":"42","author":"R Shibata","year":"2007","unstructured":"Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K., Kihara, S., Colucci, W. S., et al. (2007). Adiponectin protects against the development of systolic dysfunction following myocardial infarction. Journal of Molecular and Cellular Cardiology, 42, 1065\u20131074.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9298_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2004.11.022","volume":"507","author":"K Wada","year":"2005","unstructured":"Wada, K., Fujimori, A., Matsukawa, U., Arai, Y., Sudoh, K., Yatsu, T., et al. (2005). Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure. European Journal of Pharmacology, 507, 145\u2013151.","journal-title":"European Journal of Pharmacology"},{"key":"9298_CR17","first-page":"1387","volume":"12","author":"ZM Li","year":"2009","unstructured":"Li, Z. M. (2009). The clinical research of Guangzao fufang capsule on angina. Chinese Journal of Integrative Medicine on Cardio\/cerebrovascular Disease, 12, 1387\u20131388.","journal-title":"Chinese Journal of Integrative Medicine on Cardio\/cerebrovascular Disease"},{"key":"9298_CR18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cardiores.2006.01.013","volume":"70","author":"EA Jankowska","year":"2006","unstructured":"Jankowska, E. A., Ponikowski, P., Piepoli, M. F., Banasiak, W., Anker, S. D., & Poole-Wilson, P. A. (2006). Autonomic imbalance and immune activation in chronic heart failure pathophysiological links. Cardiovascular Research, 70, 434\u2013445.","journal-title":"Cardiovascular Research"},{"key":"9298_CR19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1742-1241.2007.01295.x","volume":"61","author":"KZ Gong","year":"2007","unstructured":"Gong, K. Z., Song, G., Spiers, J. P., Kelso, E. J., & Zhang, Z. G. (2007). Activation of immune and inflammatory systems in chronic heart failure: Novel therapeutic approaches. International Journal of Clinical Practice, 61, 611\u2013621.","journal-title":"International Journal of Clinical Practice"},{"key":"9298_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.med.52.1.15","volume":"52","author":"A Blum","year":"2001","unstructured":"Blum, A., & Miller, H. (2001). Pathophysiological role of cytokines in congestive heart failure. Annual Review of Medicine, 52, 15\u201327.","journal-title":"Annual Review of Medicine"},{"key":"9298_CR21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","volume":"111","author":"M Valgimigli","year":"2005","unstructured":"Valgimigli, M., Ceconi, C., Malagutti, P., Merli, E., Soukhomovskaia, O., Francolini, G., et al. (2005). Tumor necrosis factor-\u03b1 receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study. Circulation, 111, 863\u2013870.","journal-title":"Circulation"},{"key":"9298_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9149(02)02494-3","volume":"90","author":"AP Bolger","year":"2002","unstructured":"Bolger, A. P., Sharma, R., von Haehling, S., Doehner, W., Oliver, B., Rauchhaus, M., et al. (2002). Effect of interleukin-10 on the production of tumor necrosis factoralpha by peripheral blood mononuclear cells from patients with chronic heart failure. American Journal of Cardiology, 90, 384\u2013389.","journal-title":"American Journal of Cardiology"},{"key":"9298_CR23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.CIR.0000014686.73212.DA","volume":"105","author":"AL Chancey","year":"2002","unstructured":"Chancey, A. L., Brower, G. L., Peterson, J. T., & Janicki, J. S. (2002). Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation, 105, 1983\u20131988.","journal-title":"Circulation"},{"key":"9298_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20060110","volume":"112","author":"S Yasuda","year":"2007","unstructured":"Yasuda, S., Miyazaki, S., Kinoshita, H., Nagaya, N., Kanda, M., Goto, Y., & Nonogi, H. (2007). Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction. Clinical Science (London), 112, 43\u201349.","journal-title":"Clinical Science (London)"},{"key":"9298_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1620\/tjem.227.161","volume":"227","author":"Y Gu","year":"2012","unstructured":"Gu, Y., Wang, X., Wang, X., Yuan, M., Wu, G., Hu, J., et al. (2012). Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-\u03baB pathway. Tohoku Journal of Experimental Medicine, 227, 161\u2013170.","journal-title":"Tohoku Journal of Experimental Medicine"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-014-9298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-014-9298-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-014-9298-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:06:21Z","timestamp":1598526381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-014-9298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["9298"],"URL":"https:\/\/doi.org\/10.1007\/s12012-014-9298-3","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}